Private equity firm Grant Avenue Capital has completed a recapitalization of CREO, along with the healthcare firm’s founding partners.
The terms of the transaction were not disclosed, but Grant Avenue’s typical investment size ranges from $25 million to $75 million. CREO is a provider of strategy, M&A, digital transformation, cybersecurity, IT quality and regulatory compliance consulting services to life sciences and healthcare organizations.
Founded in North Carolina’s Research Triangle Park by Chief Executive Officer Susan Acker-Walsh and President Mike Townley in 2015, CREO aims to provide holistic solutions to its life science and healthcare company customers that help them reach their full potential and overcome multi-faceted industry challenges.
“CREO is well recognized for its unique blend of value creation services for industry organizations, leaders and investors, and we are pleased to partner with the Company at this pivotal point in its evolution,” added Brian Berkin, managing director at Grant Avenue. “Susan and Mike have established an incredible platform for helping life sciences and healthcare organizations grow. Grant Avenue is eager to help strengthen CREO’s reach and impact across new geographies, partnerships, service offerings, and M&A.”
Grant Avenue said it will work hand-in-glove with Acker-Walsh and Townley to continue executing CREO’s business objectives to drive value for CREO customers and the healthcare industry at large.
“CREO and Grant Avenue share a vision of making good companies better so that they can create a better, healthier world,” said Acker-Walsh. ”Grant Avenue’s significant healthcare investment experience, deep industry network, and flexible capital approaches make the firm an ideal partner for us as we continue to build on our successful growth.”
Townley added that the support from Grant Avenue will allow them to provide customers with additional growth services they demand and deserve.
Clearsight Advisors served as financial advisor to CREO and Crosstree Capital Partners served as financial advisor to Grant Avenue in connection with the transaction.
